Detalhe da pesquisa
1.
Hepatitis B core-related antigen serum levels are associated with significant liver fibrosis in treatment-naive chronic HBV infection patients.
J Viral Hepat
; 29(6): 438-446, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35357759
2.
Outcome of Chinese patients with hepatitis B at 96 weeks after functional cure with IFN versus combination regimens.
Liver Int
; 41(7): 1498-1508, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486874
3.
The reduction in CD8+PD-1+ T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patients.
BMC Infect Dis
; 20(1): 590, 2020 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32778058
4.
Predictors of sustained functional cure in hepatitis B envelope antigen-negative patients achieving hepatitis B surface antigen seroclearance with interferon-alpha-based therapy.
J Viral Hepat
; 26 Suppl 1: 32-41, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31380582
5.
Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levels.
J Viral Hepat
; 26 Suppl 1: 42-49, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31380591
6.
Evaluation of different agricultural wastes for the production of fruiting bodies and bioactive compounds by medicinal mushroom Cordyceps militaris.
J Sci Food Agric
; 97(10): 3476-3480, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27747890
7.
Pseudo-Chédiak-Higashi inclusions in relapsed acute lymphoblastic leukaemia.
Br J Haematol
; 195(3): 300, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34166523
8.
[Efficacy of pegylated-interferon alpha-2a treatment in patients with HBeAg-positive chronic hepatitis B and partial viral response to nucleoside analogue therapy].
Zhonghua Gan Zang Bing Za Zhi
; 23(11): 826-31, 2015 Nov.
Artigo
em Zh
| MEDLINE | ID: mdl-26743242
9.
[The correlation study of the expression of VEGF with t-PA and PAI expression in plasma and intraocular tissue in proliferative diabetic retinopathy].
Zhonghua Yan Ke Za Zhi
; 50(6): 448-53, 2014 Jun.
Artigo
em Zh
| MEDLINE | ID: mdl-25241978
10.
Hepatitis B core-related antigen serum levels may be a predictor of acute flare of chronic hepatitis B among pregnant women in the immune-tolerant phase of chronic HBV infection after short-course antiviral therapy.
Virulence
; 14(1): 2186335, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36864005
11.
Changes of natural killer cells' phenotype in patients with chronic hepatitis B in intermittent interferon therapy.
Front Immunol
; 14: 1116689, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36793722
12.
Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity.
Front Immunol
; 14: 1122048, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36875136
13.
Severe coagulopathy caused by cefminox sodium in a liver cirrhosis patient: a case report.
Infect Agent Cancer
; 17(1): 30, 2022 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710562
14.
Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection.
Front Immunol
; 13: 893512, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35634301
15.
Expression of Functional Molecule on Plasmacytoid Dendritic Cells Is Associated With HBsAg Loss in HBeAg-Positive Patients During PEG-IFN α-2a Treatment.
Front Immunol
; 13: 891424, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35663955
16.
Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients.
Front Immunol
; 13: 892031, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603222
17.
Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B.
Front Immunol
; 13: 1024333, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36203581
18.
Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B.
Front Immunol
; 13: 1036612, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36353632
19.
Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapy.
Front Immunol
; 13: 1067362, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36479104
20.
Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative.
Front Immunol
; 13: 1113070, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36685494